Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 5, 2021

Total Value ($000): $582,316 (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc (BBIO) 48.7%

Value ($000) $283,687 Shares 3,989,412 Est. Cost $27.40 Unrealized +76.0%

— Eidos Therapeutics, Inc. (EIDIX) 25.4%

Value ($000) $147,847 Shares 1,123,630 Est. Cost $13.76 Unrealized —

HRMY HARMONY BIOSCIENCES HLDGS IN (HRMY) 5.2%

Value ($000) $30,468 Shares 842,815 Est. Cost $36.46 Unrealized +10.7%

— Spruce Biosciences, Inc. (SPRB) 5.0%

Value ($000) $29,306 Shares 1,205,511 Est. Cost $24.31 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 3.9%

Value ($000) $22,796 Shares 1,025,000 Est. Cost $10.24 Unrealized +102.5%

— AVROBIO, Inc. (AVRO) 2.4%

Value ($000) $14,076 Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 2.3%

Value ($000) $13,309 Shares 1,691,151 Est. Cost $8.00 Unrealized —

— POSEIDA THERAPEUTICS INC (PSTX) 2.0%

Value ($000) $11,445 Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Verona Pharma plc (VRNA) 1.6%

Value ($000) $9,327 Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Atreca Inc (BCEL) 1.1%

Value ($000) $6,261 Shares 387,653 Est. Cost $18.84 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.7%

Value ($000) $4,105 Shares 634,455 Est. Cost $10.31 Unrealized -59.1%

— Marker Therapeutics, Inc. (MRKR) 0.5%

Value ($000) $2,900 Shares 2,000,000 Est. Cost $5.55 Unrealized —

— ObsEva SA (OBSV) 0.5%

Value ($000) $2,884 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 0.3%

Value ($000) $2,010 Shares 1,010,000 Est. Cost $0.89 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.2%

Value ($000) $1,433 Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.1%

Value ($000) $462 Shares 191,028 Est. Cost $1.49 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc (BBIO)	3,989,412	$283,687	48.7%	$27.40	+76.0%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$147,847	25.4%	$13.76	—	COM	28249H104
HRMY	HARMONY BIOSCIENCES HLDGS IN (HRMY)	842,815	$30,468	5.2%	$36.46	+10.7%	COM	413197104
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$29,306	5.0%	$24.31	—	COM	85209E109
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$22,796	3.9%	$10.24	+102.5%	COM	87164F105
—	AVROBIO, Inc. (AVRO)	1,009,779	$14,076	2.4%	$16.72	—	COM	05455M100
—	Aeglea Biotherapeutics Inc (AGLE)	1,691,151	$13,309	2.3%	$8.00	—	COM	00773J103
—	POSEIDA THERAPEUTICS INC (PSTX)	1,043,267	$11,445	2.0%	$8.87	—	COM	73730P108
—	Verona Pharma plc (VRNA)	1,332,485	$9,327	1.6%	$7.38	—	COM	925050106
—	Atreca Inc (BCEL)	387,653	$6,261	1.1%	$18.84	—	CL A COM	04965G109
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$4,105	0.7%	$10.31	-59.1%	COM	00461U105
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$2,900	0.5%	$5.55	—	COM	57055L107
—	ObsEva SA (OBSV)	1,386,338	$2,884	0.5%	$12.66	—	COM	H5861P103
—	Sunesis Pharmaceuticals, Inc. (SNSS)	1,010,000	$2,010	0.3%	$0.89	—	COM	867328700
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$1,433	0.2%	$2.15	—	COM	98979H202
—	Nabriva Therapeutics plc (NBRV)	191,028	$462	0.1%	$1.49	—	SHS	G63637105